Inicio › Cáncer de seno › Nevada › Reno
Ensayos clínicos de Cáncer de seno en Reno, NV
13 estudios para Cáncer de seno buscan participantes en centros de Reno y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- Cancer Care Specialists, Reno
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Renown Regional Medical Center, Reno
- Saint Mary's Regional Medical Center, Reno
- Carson Tahoe Regional Medical Center, Carson City · A 25 mi de distancia
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
ReclutandoFase 2
- Cancer Care Specialists, Reno
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ReclutandoFase 3
- Renown Regional Medical Center ( Site 0041), Reno
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
ReclutandoFase 1/2
- Renown Regional Medical Center, Reno
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Reno
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ReclutandoFase 3
- Renown Health Medical Oncology, Reno
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
ReclutandoEstudio observacional
- Cancer Care Specialist of Reno, Reno
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Renown Regional Medical Center, Reno
- Saint Mary's Regional Medical Center, Reno
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · A 24 mi de distancia
- y 1 más
E-Mindfulness Approaches for Living After Breast Cancer
ReclutandoFase 3
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · A 24 mi de distancia
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
ReclutandoFase 3
- Renown Regional Medical Centre, Reno
- Cancer Care Specialists, Reno
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Renown Regional Medical Center, Reno
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · A 24 mi de distancia
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
ReclutandoFase 1
- Renown Regional Medical Center, Reno
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY134 estudios
- Houston, TX126 estudios
- Boston, MA111 estudios
- Nashville, TN80 estudios
- Los Angeles, CA72 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Durham, NC63 estudios
- Queens, NY63 estudios
- Chicago, IL58 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Reno
- Cáncer de pulmón de células no pequeñas16 estudios
- Cáncer de pulmón9 estudios
- Degeneración macular8 estudios
- Atrofia geográfica8 estudios
- Cáncer de ovario7 estudios
- Cáncer (todos los tipos)7 estudios
- Cáncer del colon y del recto5 estudios
- Leucemia mielógena aguda5 estudios
- Cáncer metastásico5 estudios
- Cáncer de páncreas5 estudios
- Cáncer de colon5 estudios
- Cáncer de recto4 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.